Active surveillance of patients who have sentinel node positive melanoma : an international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT‐2)
autor
vastutusandmed
Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, James Sun, Dennis Kirichenko, Michael J. Carr, Avinash Sharma, Edmund K. Bartlett, Amanda A. G. Nijhuis, John F. Thompson, Tina J. Hieken, Lisa Kottschade, Jennifer Downs, David E. Gyorki, Emma Stahlie, Alexander van Akkooi, David W. Ollila, Jill Frank, Yun Song, Giorgos Karakousis, Marc Moncrieff, Jenny Nobes, John Vetto, Dale Han, Jeffrey M. Farma, Jeremiah L. Deneve, Martin D. Fleming, Matthew C. Perez, Michael C. Lowe, Roger Olofsson Bagge, Jan Mattsson, Ann Y. Lee, Russell S. Berman, Harvey Chai, Hidde M. Kroon, Juri Teras, Roland M. Teras, Norma E. Farrow, Georgia Beasley, Jane Yuet Ching Hui, Lukas Been, Schelto Kruijff, Youngchul Kim, Syeda Mahrukh Hussnain Naqvi, Amod A. Sarnaik, Vernon K. Sondak, Jonathan S. Zager
allikas
Cancer
kirjastus/väljaandja
American Cancer Society
ajakirja aastakäik number kuu
vol. 127, 13
ilmumisaasta
leheküljed
p. 2251-2261
märksõna
ISSN
1097-0142
Open Access
Open Access
teaduspublikatsioon
teaduspublikatsioon
klassifikaator
TTÜ struktuuriüksus
keel
inglise
Broman, K. K., Hughes, T., Dossett, L., Sun, J., Kirichenko, D., Carr, M. J., Sharma, A., Bartlett, E. K., Nijhuis, A. A. G., Thompson, J. F., Teras, J., Teras, R. M. et al. Active surveillance of patients who have sentinel node positive melanoma : an international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT‐2) // Cancer (2021) vol. 127, 13, p. 2251-2261.